FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Jan Basile

Research Profile

Disorders

Chemicals & Drugs

Concepts & Ideas

Procedures

Geographic Areas

United States

Activities & Behaviors

Life Style

Co-author Network

Publications

TOP 3
Michael J Bloch; Jan Basile
Analysis of recent papers in hypertension: Treatment of obstructive sleep apnea with continuous positive airway pressure appears to decrease the incidence of incident hypertension.
Jan Basile; Michael J Bloch
Analysis of recent papers in hypertension: nighttime administration of at least one antihypertensive medication is associated with better blood pressure control and cardiovascular outcomes in patients with type 2 diabetes or chronic kidney disease.
Jan Basile; Michael J Bloch
Exposure to air pollution increases the incidence of hypertension and diabetes in black women living in Los Angeles.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Jan Basile (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Michael J Bloch; Jan Basile
Analysis of recent papers in hypertension: Treatment of obstructive sleep apnea with continuous positive airway pressure appears to decrease the incidence of incident hypertension.
Journal of clinical hypertension (Greenwich, Conn.) 2013;15(2):85-7.
2013: Jan Basile; Michael J Bloch
Analysis of recent papers in hypertension: nighttime administration of at least one antihypertensive medication is associated with better blood pressure control and cardiovascular outcomes in patients with type 2 diabetes or chronic kidney disease.
Journal of clinical hypertension (Greenwich, Conn.) 2013;15(1):2-4.
2012: Jan Basile; Michael J Bloch
Exposure to air pollution increases the incidence of hypertension and diabetes in black women living in Los Angeles.
Journal of clinical hypertension (Greenwich, Conn.) 2012;14(11):819-20.
2012: Michael J Bloch; Jan Basile
What should be the target blood pressure in patients with chronic kidney disease? Data from the Kidney Early Evaluation Program.
Journal of clinical hypertension (Greenwich, Conn.) 2012;14(7):472-4.
2012: Jan Basile; Michael J Bloch
NHANES data highlight the clinical characteristics of those with poorly controlled hypertension.
Journal of clinical hypertension (Greenwich, Conn.) 2012;14(4):267-8.
2012: William Cushman; Jeffrey A Cutler; Barry R Davis; Paula T Einhorn; Charles E Ford; Richard H Grimm; Bruce P Hamilton; L Julian Haywood; Stephen T Ong; Suzanne Oparil; Linda B Piller; Sara Pressel; Jeffrey L Probstfield; Lara M Simpson; Carol Stanford; Robert J Weiss; Paul K Whelton; Jackson T Wright; Michael H Alderman; Jan Basile; Henry R Black
Mortality and morbidity during and after the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial.
Journal of clinical hypertension (Greenwich, Conn.) 2012;14(1):20-31.
2011: Jan Basile
A new approach to glucose control in type 2 diabetes: the role of kidney sodium-glucose co-transporter 2 inhibition.
Postgraduate medicine 2011;123(4):38-45.
2010: Jan Basile; Joel Neutel
Overcoming clinical inertia to achieve blood pressure goals: the role of fixed-dose combination therapy.
Therapeutic advances in cardiovascular disease 2010;4(2):119-27.
2010: Jan Basile
Critical appraisal of amlodipine and olmesartan medoxomil fixed-dose combination in achieving blood pressure goals.
Integrated blood pressure control 2010;3():91-104.
2009: Michael J Bloch; Jan Basile
Largest meta-analysis to date suggests that patients at risk for cardiovascular disease events derive benefit from antihypertensive therapy regardless of baseline blood pressure and to reduce vascular events, lowering blood pressure is more important than choice of antihypertensive drug class.
Journal of clinical hypertension (Greenwich, Conn.) 2009;11(12):743-5.
2009: Jan Basile; Peter P. Toth
Angiotensin receptor blockers: role in hypertension management, cardiovascular risk reduction, and nephropathy.
Southern medical journal 2009;102(10 Suppl):S1-S12.
2009: Jan Basile
Lessons learned from the ONTARGET and TRANSCEND trials.
Current atherosclerosis reports 2009;11(5):371-6.
2009: Scott H Stewart; Adrian Reuben; Walter A Brzezinski; David G Koch; Jan Basile; Patrick K Randall; Peter M Miller
Preliminary evaluation of phosphatidylethanol and alcohol consumption in patients with liver disease and hypertension.
Alcohol and alcoholism (Oxford, Oxfordshire) 2009;44(5):464-7.
2009: Michael J Bloch; Jan Basile
Heart failure in people younger than 50 years is more common in black than white Americans and is closely associated with poorly treated and controlled hypertension: the CARDIA study.
Journal of clinical hypertension (Greenwich, Conn.) 2009;11(7):388-90.
2009: Brent M Egan; Jan Basile; Shakaib U Rehman; Phillip B Davis; Curt H Grob; Jessica Flynn Riehle; Christine A Walters; Daniel T Lackland; Carmen Merali; Jean E Sealey; John H Laragh
Plasma Renin test-guided drug treatment algorithm for correcting patients with treated but uncontrolled hypertension: a randomized controlled trial.
American journal of hypertension 2009;22(7):792-801.
2009: Jan Basile
New therapeutic options in patients prone to hypertension: a focus on direct Renin inhibition and aldosterone blockade.
The American journal of the medical sciences 2009;337(6):438-44.
2009: Michael J Bloch; Jan Basile
Analysis of Recent Papers in Hypertension.
Journal of clinical hypertension (Greenwich, Conn.) 2009;11(5):292-95.
2009: Michael J Bloch; Jan Basile
Analysis of recent papers in hypertension.
Journal of clinical hypertension (Greenwich, Conn.) 2009;11(4):238-40.
2009: Jan Basile
Blood pressure responder rates versus goal rates: which metric matters?
Therapeutic advances in cardiovascular disease 2009;3(2):157-74.
2009: Jan Basile
Antihypertensive therapy, new-onset diabetes, and cardiovascular disease.
International journal of clinical practice 2009;63(4):656-66.
2009: Michael J Bloch; Jan Basile
Analysis of recent papers in hypertension, Jan Basile, MD, Senior Editor.
Journal of clinical hypertension (Greenwich, Conn.) 2009;11(2):102-5.
2009: Michael J Bloch; Jan Basile
Analysis of recent papers in hypertension. Lack of legacy effect with more intensive blood pressure control in the long-term follow-up of the United Kingdom Prospective Diabetes Study.
Journal of clinical hypertension (Greenwich, Conn.) 2009;11(1):46-9.
2009: Michael E Ernst; Barry L Carter; Jan Basile
All thiazide-like diuretics are not chlorthalidone: putting the ACCOMPLISH study into perspective.
Journal of clinical hypertension (Greenwich, Conn.) 2009;11(1):5-10.
2008: Michael J Bloch; Jan Basile
Analysis of recent papers in hypertension.
Journal of clinical hypertension (Greenwich, Conn.) 2008;10(12):956-8.
2008: Michael J Bloch; Jan Basile
In angiotensin-converting enzyme inhibitor-intolerant individuals, the angiotensin receptor blocker telmisartan does not reduce the incidence of major cardiovascular events in high-risk patients: lessons learned from the Telmisartan Randomized Assessment Study in ACE-Intolerant Subjects Wtih Cardiovascular Disease (TRANSCEND).
Journal of clinical hypertension (Greenwich, Conn.) 2008;10(11):876-80.
2008: Michael J Bloch; Jan Basile
Analysis of recent papers in hypertension Jan Basile , MD , Senior Editor.
Journal of clinical hypertension (Greenwich, Conn.) 2008;10(10):805-7.
2008: Elaine M Furmaga; Francesca E Cunningham; William C Cushman; Diane Dong; Rong Jiang; Jan Basile; Lois A Katz; Gale H Rutan; Dan R Berlowitz; Vasilios Papademetriou; Peter A Glassman
National utilization of antihypertensive medications from 2000 to 2006 in the Veterans Health Administration: focus on thiazide diuretics.
Journal of clinical hypertension (Greenwich, Conn.) 2008;10(10):770-8.
2008: William C Cushman; Charles E Ford; Paula T Einhorn; Jackson T Wright; Richard A Preston; Barry R Davis; Jan Basile; Paul K Whelton; Robert J Weiss; Arnaud Bastien; Donald L Courtney; Bruce P Hamilton; Kent Kirchner; Gail T Louis; Tamrat M Retta; Donald G Vidt
Blood pressure control by drug group in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
Journal of clinical hypertension (Greenwich, Conn.) 2008;10(10):751-60.
2008: Michael J Bloch; Jan Basile
Analysis of recent papers in hypertension.
Journal of clinical hypertension (Greenwich, Conn.) 2008;10(9):735-7.
2008: Jan Basile
Rationale for fixed-dose combination therapy to reach lower blood pressure goals.
Southern medical journal 2008;101(9):918-24.
2008: Mahboob Rahman; Charles Baimbridge; Barry R Davis; Joshua I Barzilay; Jan Basile; Mario A Henriquez; Anne Huml; Nelson Kopyt; Gail T Louis; Sara Pressel; Clive Rosendorff; Sithiporn Sastrasinh; Carol Stanford
Progression of kidney disease in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin versus usual care: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
American journal of kidney diseases : the official journal of the National Kidney Foundation 2008;52(3):412-24.
2008: Michael J Bloch; Jan Basile
Primary hyperaldosteronism in patients with resistant hypertension may be less prevalent than previously reported: evidence against an epidemic.
Journal of clinical hypertension (Greenwich, Conn.) 2008;10(8):655-7.
2008: Howard S Weintraub; Jan Basile
The pleiotropic effects of antihypertensive agents: do they account for additional cardiovascular benefit beyond BP reduction?
Southern medical journal 2008;101(8):818-23.
2008: Michael J Bloch; Jan Basile
Analysis of recent papers in hypertension.
Journal of clinical hypertension (Greenwich, Conn.) 2008;10(7):582-4.
2008: Michael J Bloch; Jan Basile
Treating hypertension in the oldest of the old reduces total mortality: results of the Hypertension in the Very Elderly Trial (HYVET).
Journal of clinical hypertension (Greenwich, Conn.) 2008;10(6):501-3.
2008: Michael J Bloch; Jan Basile
Analysis of recent papers in hypertension: a simple office-based tool to predict the development of hypertension.
Journal of clinical hypertension (Greenwich, Conn.) 2008;10(5):415-6.
2008: Michael J Bloch; Jan Basile
Self measurement of blood pressure at home should complement rather than replace office blood pressure management.
Journal of clinical hypertension (Greenwich, Conn.) 2008;10(4):324-6.
2008: Michael J Bloch; Jan Basile
Chronotherapy in patients with chronic kidney disease to reduce nighttime blood pressure--not ready for prime time.
Journal of clinical hypertension (Greenwich, Conn.) 2008;10(3):249-51.
2008: Michael J Bloch; Jan Basile
Cholesterol ester transfer protein inhibition with torcetrapib leads to an increase in cardiovascular events: an effect that is unlikely to be the result of increases in blood pressure alone.
Journal of clinical hypertension (Greenwich, Conn.) 2008;10(2):160-3.
2008: Henry R Black; Barry Davis; Joshua I Barzilay; Chuke Nwachuku; Charles Baimbridge; Horia Marginean; Jackson T Wright; Jan Basile; Nathan D Wong; Paul Whelton; Richard A Dart; Udho Thadani
Metabolic and clinical outcomes in nondiabetic individuals with the metabolic syndrome assigned to chlorthalidone, amlodipine, or lisinopril as initial treatment for hypertension: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
Diabetes care 2008;31(2):353-60.
2008: Jackson T Wright; Sonja Harris-Haywood; Sara Pressel; Joshua I Barzilay; Charles Baimbridge; Charles J Bareis; Jan Basile; Henry R Black; Richard Dart; Alok K Gupta; Bruce P Hamilton; Paula T Einhorn; L Julian Haywood; Syed Z A Jafri; Gail T Louis; Paul K Whelton; Cranford L Scott; Debra L Simmons; Carol Stanford; Barry R Davis
Clinical outcomes by race in hypertensive patients with and without the metabolic syndrome: Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
Archives of internal medicine 2008;168(2):207-17.
2008: Kenneth A Jamerson; Jan Basile
Prompt, aggressive BP lowering in high-risk patients.
Journal of clinical hypertension (Greenwich, Conn.) 2008;10(1 Suppl 1):40-8.
2008: Jan Basile
The importance of prompt blood pressure control.
Journal of clinical hypertension (Greenwich, Conn.) 2008;10(1 Suppl 1):13-9.
2008: Jan Basile
Shifting paradigms in defining and treating hypertension: addressing global risk with combination therapy.
Journal of clinical hypertension (Greenwich, Conn.) 2008;10(1 Suppl 1):2-3.
2008: Michael J Bloch; Jan Basile
Advance trial supports current recommendations for blood pressure goals and not the use of any specific combination of antihypertensive agents in patients with type 2 diabetes.
Journal of clinical hypertension (Greenwich, Conn.) 2008;10(1):81-4.
2007: Carlos M Ferrario; Jan Basile; William Bestermann; Edward Frohlich; Mark Houston; Daniel T Lackland; Ronald D Smith; Daniel L Wise
The role of noninvasive hemodynamic monitoring in the evaluation and treatment of hypertension.
Therapeutic advances in cardiovascular disease 2007;1(2):113-8.
2007: michael J Bloch; Jan Basile
Thresholds for diastolic blood pressure reduction in older patients with isolated systolic hypertension appear to be different depending on the presence or absence of underlying coronary heart disease.
Journal of clinical hypertension (Greenwich, Conn.) 2007;9(12):977-9.
2007: Jan Basile
Clinical considerations and practical recommendations for the primary care practitioner in the management of anemia of chronic kidney disease.
Southern medical journal 2007;100(12):1200-7.
2007: Michael J Bloch; Jan Basile
Development of new-onset diabetes mellitus is associated with an increased risk for cardiac morbidity: the VALUE Trial.
Journal of clinical hypertension (Greenwich, Conn.) 2007;9(11):905-7.
2007: Michael J Bloch; Jan Basile
Number of visits at goal blood pressure is associated with improved cardiovascular outcomes--a post hoc analysis of the INVEST trial.
Journal of clinical hypertension (Greenwich, Conn.) 2007;9(10):811-3.
2007: Michael J Bloch; Jan Basile
Blood pressure reduction appears more important than specific antihypertensive agent used to improve diastolic function.
Journal of clinical hypertension (Greenwich, Conn.) 2007;9(9):720-2.
2007: Michael J Bloch; Jan Basile
AHA scientific statement: new blood pressure targets for high-risk and established coronary artery disease patients.
Journal of clinical hypertension (Greenwich, Conn.) 2007;9(8):649-51.
2007: Jan Basile; Henry R Black; John M Flack; Joseph L Izzo
The role of therapeutic inertia and the use of fixed-dose combination therapy in the management of hypertension.
Journal of clinical hypertension (Greenwich, Conn.) 2007;9(8):636-45.
2007: Joshua I Barzilay; Richard Grimm; William Cushman; Alain G Bertoni; Jan Basile
Getting to goal blood pressure: why reserpine deserves a second look.
Journal of clinical hypertension (Greenwich, Conn.) 2007;9(8):591-4.
2007: Michael J Bloch; Jan Basile
Spironolactone found effective for patients with resistant hypertension in ASCTT-BPLA.
Journal of clinical hypertension (Greenwich, Conn.) 2007;9(7):579-81.
2007: Michael J Bloch; Jan Basile
Defining the role of angiotensin receptor blocker therapy in Japanese persons with underlying vascular disease: the Jikei Heart Study.
Journal of clinical hypertension (Greenwich, Conn.) 2007;9(7):576-9.
2007: William Cushman; Richard H Grimm; Jeffrey A Cutler; Gregory Evans; Sarah Capes; Marshall A Corson; Laurie S Sadler; Michael H Alderman; Kevin Peterson; Alain Bertoni; Jan Basile
Rationale and design for the blood pressure intervention of the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial.
The American journal of cardiology 2007;99(12A):44i-55i.
2007: Michael J Bloch; Jan Basile
Higher 24-hour ambulatory blood pressure measurement and non-dipping status associated with cerebrovascular white matter disease.
Journal of clinical hypertension (Greenwich, Conn.) 2007;9(6):478-80.
2007: Michael J Bloch; Jan Basile
Analysis of recent papers in hypertension.
Journal of clinical hypertension (Greenwich, Conn.) 2007;9(5):396.
2007: Jan Basile
Recognizing the link between CKD and CVD in the primary care setting: accurate and early diagnosis for timely and appropriate intervention.
Southern medical journal 2007;100(5):499-505.
2007: Michael J Bloch; Jan Basile
Diagnosis and management of renovascular disease and renovascular hypertension.
Journal of clinical hypertension (Greenwich, Conn.) 2007;9(5):381-9.
2007: Jan Basile
Fixed-dose combination therapy in the treatment of hypertension: ready for prime time.
Southern medical journal 2007;100(4):343-4.
2007: Michael J Bloch; Jan Basile
Blood pressure control rates in Spain are further improved using daytime ambulatory measurements than when using conventional office based measurement.
Journal of clinical hypertension (Greenwich, Conn.) 2007;9(4):299-301.
2007: Michael J Bloch; Jan Basile
Aliskerin, an oral renin inhibitor, in combination with a thiazide diuretic, ace inhibitor, or angiotensin receptor antagonist reduces 24-hour blood pressure and suppresses plasma renin activity.
Journal of clinical hypertension (Greenwich, Conn.) 2007;9(4):297-9.
2007: Michael J Bloch; Jan Basile
Comparative effectiveness of medical therapy compared with initial percutaneous intervention in the treatment of atherosclerotic renal artery stenosis.
Journal of clinical hypertension (Greenwich, Conn.) 2007;9(3):229-31.
2007: Michael J Bloch; Jan Basile
Hypertension prevalence increases and hypertension control rates improve in the United States: 2003-2004.
Journal of clinical hypertension (Greenwich, Conn.) 2007;9(2):147-9.
2007: Michael J Bloch; Jan Basile
Effects of a calcium channel blocker and a statin-based treatment regimen in the Anglo-Scandinavian Cardiac Outcomes Trial.
Journal of clinical hypertension (Greenwich, Conn.) 2007;9(2):145-7.
2007: Michael H Davidson; Jan Basile; Alan J Garber; Robert A Phillips
Reducing the risk of stroke through appropriate targets and treatments.
Preventive cardiology 2007;10(4):215-21.
2006: Jan Basile; Hector Ventura
A historical look at hypertension: celebrating 100 years with the Southern Medical Association.
Southern medical journal 2006;99(12):1412-3.
2006: Michael J Bloch; Jan Basile
Analysis of recent papers in hypertension.
Journal of clinical hypertension (Greenwich, Conn.) 2006;8(12):901-3.
2006: Brent M Egan; Daniel T Lackland; Priscilla E Pemu; Katharine H Hendrix; Jan Basile; Shakaib U Rehman; Eni C Okonofua; Quarshie Alexander; Adesifayo Oduwole; Anekwe E Onwuanyi; James _ Reed; Chamberlain _ Obialo; Elizabeth Ofili
Cardiovascular risk factor control in communities--update from the ASH Carolinas-Georgia Chapter, the Hypertension Initiative, and the Community Physicians' Network.
Journal of clinical hypertension (Greenwich, Conn.) 2006;8(12):879-86.
2006: William Cushman; Jan Basile
Achieving blood pressure goals: why aren't we?
Journal of clinical hypertension (Greenwich, Conn.) 2006;8(12):865-72.
2006: Joshua I Barzilay; Barry R Davis; Jeffrey A Cutler; Sara Pressel; Paul K Whelton; Jan Basile; Karen L Margolis; Stephen T Ong; Laurie S Sadler; John Summerson
Fasting glucose levels and incident diabetes mellitus in older nondiabetic adults randomized to receive 3 different classes of antihypertensive treatment: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
Archives of internal medicine 2006;166(20):2191-201.
2006: Michael J Bloch; Jan Basile
Correction of thiazide-induced hypokalemia prevents hyperglycemia and incident diabetes mellitus.
Journal of clinical hypertension (Greenwich, Conn.) 2006;8(10):751-3.
2006: Jan Basile; Mark Houston; Carlos M Ferrario
Incremental risk-factor reduction improves overall cardiovascular benefit: is it time to abandon the silos?
Journal of clinical hypertension (Greenwich, Conn.) 2006;8(10):686-8.
2006: Michael J Bloch; Jan Basile
Short-term treatment of sleep apnea with nocturnal continuous positive airway pressure does not improve blood pressure in patients with well controlled hypertension.
Journal of clinical hypertension (Greenwich, Conn.) 2006;8(9):673-5.
2006: Michael J Bloch; Jan Basile
Angiotensin-converting enzyme inhibitors found unsafe at any time during pregnancy.
Journal of clinical hypertension (Greenwich, Conn.) 2006;8(9):671-3.
2006: Michael J Bloch; Jan Basile
Clinical insights into the diagnosis and management of atherosclerotic renal artery disease.
Current atherosclerosis reports 2006;8(5):412-20.
2006: Frans Leenen; Chuke Nwachuku; Henry R Black; William Cushman; Barry R Davis; Lara M Simpson; Michael H Alderman; Steven A Atlas; Jan Basile; Aloysius B Cuyjet; Richard Dart; James V Felicetta; Richard H Grimm; L Julian Haywood; Syed Z A Jafri; Michael A Proschan; Udho Thadani; Paul K Whelton; Jackson T Wright
Clinical events in high-risk hypertensive patients randomly assigned to calcium channel blocker versus angiotensin-converting enzyme inhibitor in the antihypertensive and lipid-lowering treatment to prevent heart attack trial.
Hypertension 2006;48(3):374-84.
2006: Jan Basile
Management of global risk across the continuum of hypertensive heart disease.
Journal of clinical hypertension (Greenwich, Conn.) 2006;8(8 Suppl 2):21-30; quiz 39-40.
2006: Michael J Bloch; Jan Basile
Analysis of recent papers in hypertension.
Journal of clinical hypertension (Greenwich, Conn.) 2006;8(7):534-7.
2006: Michael J Bloch; Jan Basile
Chlorthalidone reduces 24-hour ambulatory systolic blood pressure more than hydrochlorothiazide.
Journal of clinical hypertension (Greenwich, Conn.) 2006;8(6):452-4.
2006: Michael J Bloch; Jan Basile
Analysis of recent papers in hypertension: differences in central aortic blood pressure explain outcome differences in ASCOT: the CAFE substudy; and rimonabant improves multiple cardiometabolic parameters in overweight and obese individuals.
Journal of clinical hypertension (Greenwich, Conn.) 2006;8(5):376-80.
2006: Michael J Bloch; Jan Basile
Analysis of recent papers in hypertension.
Journal of clinical hypertension (Greenwich, Conn.) 2006;8(4):299-302.
2006: Michael J Bloch; Jan Basile
Routine office blood pressure measurements are often higher than standardized or ambulatory readings.
Journal of clinical hypertension (Greenwich, Conn.) 2006;8(3):225-7.
2006: Michael J Bloch; Jan Basile
The presence of hyperlipidemia predicts the future risk of hypertension.
Journal of clinical hypertension (Greenwich, Conn.) 2006;8(3):224-5.
2006: Jan Basile; S Chrysant
The importance of early antihypertensive efficacy: the role of angiotensin II receptor blocker therapy.
Journal of human hypertension 2006;20(3):169-75.
2006: Michael J Bloch; Jan Basile
Analysis of recent papers in hypertension.
Journal of clinical hypertension (Greenwich, Conn.) 2006;8(2):142-4.
2006: Peter M Miller; Claudia Spies; Tim Neumann; Martin A Javors; A M Hoyumpa; John D Roache; Amy Webb; Maryam Kashi; Francis E Sharkey; Raymond F Anton; Brent M Egan; Jan Basile; Shaun Nguyen; Michael F Fleming; Kathryn Sullivan Dillie
Alcohol biomarker screening in medical and surgical settings.
Alcoholism, clinical and experimental research 2006;30(2):185-93.
2006: Jan Basile; Mark Houston; Carlos M Ferrario
Treating the cardiometabolic syndrome: an opportunity to provide comprehensive cardiovascular risk reduction.
Journal of the cardiometabolic syndrome 2006;1(5):358-61.
2006: Michael J Bloch; Jan Basile
Analysis of recent papers in hypertension.
Journal of clinical hypertension (Greenwich, Conn.) 2006;8(1):65-6.
2005: Barry L Carter; Jan Basile
Development of diabetes with thiazide diuretics: the potassium issue.
Journal of clinical hypertension (Greenwich, Conn.) 2005;7(11):638-40.
2005: Michael J Bloch; Jan Basile
Lower levels of microalbuminuria are associated with an increased risk of coronary heart disease and death in hypertensive subjects.
Journal of clinical hypertension (Greenwich, Conn.) 2005;7(9):555-7.
2005: Michael J Bloch; Jan Basile
Analysis of recent papers in hypertension. An angiotensin receptor blocker is more effective than a calcium channel blocker in secondary stroke prevention.
Journal of clinical hypertension (Greenwich, Conn.) 2005;7(8):489-92.
2005: Marvin Moser; Jan Basile; William Cushman
Hypertension, renal disease, and cardiovascular outcomes.
Journal of clinical hypertension (Greenwich, Conn.) 2005;7(8):479-84.
2005: Hanna E Bloomfield; David B Nelson; Michelle van Ryn; B J Neil; N J Koets; Jan Basile; F F Samaha; R Kaul; J L Mehta; D Bouland
A trial of education, prompts, and opinion leaders to improve prescription of lipid modifying therapy by primary care physicians for patients with ischemic heart disease.
Quality & safety in health care 2005;14(4):258-63.
2005: Brent M Egan; Jan Basile; Robert J Chilton; Jerome D Cohen
Cardioprotection: the role of beta-blocker therapy.
Journal of clinical hypertension (Greenwich, Conn.) 2005;7(7):409-16.
2005: Michael J Bloch; Jan Basile
Analysis of recent papers in hypertension.
Journal of clinical hypertension (Greenwich, Conn.) 2005;7(6):372-5.
2005: Peter M Miller; Raymond F Anton; Brent M Egan; Jan Basile; Shaun Nguyen
Excessive alcohol consumption and hypertension: clinical implications of current research.
Journal of clinical hypertension (Greenwich, Conn.) 2005;7(6):346-51.
2005: William H Bestermann; Mark C Houston; Jan Basile; Brent M Egan; Carlos M Ferrario; Daniel T Lackland; Ralph G Hawkins; James _ Reed; Philip Rogers; Daniel Wise; Michael A Moore
Addressing the global cardiovascular risk of hypertension, dyslipidemia, diabetes mellitus, and the metabolic syndrome in the southeastern United States, part II: treatment recommendations for management of the global cardiovascular risk of hypertension, dyslipidemia, diabetes mellitus, and the metabolic syndrome.
The American journal of the medical sciences 2005;329(6):292-305.
2005: Mark C Houston; Jan Basile; William H Bestermann; Brent M Egan; Daniel T Lackland; Ralph G Hawkins; Michael A Moore; James _ Reed; Philip Rogers; Daniel Wise; Carlos M Ferrario
Addressing the global cardiovascular risk of hypertension, dyslipidemia, and insulin resistance in the southeastern United States.
The American journal of the medical sciences 2005;329(6):276-91.
2004: Michael Weber; Jan Basile; Joseph Izzo; Suzanne Oparil
Roundtable discussion: blood pressure goal attainment: meeting the challenge of the JNC 7's blood pressure goals and the role of renin-angiotensin-aldosterone system blockade.
Journal of clinical hypertension (Greenwich, Conn.) 2004;6(12):699-705.
2004: Jan Basile
The role of existing and newer calcium channel blockers in the treatment of hypertension.
Journal of clinical hypertension (Greenwich, Conn.) 2004;6(11):621-29; quiz 630-1.
2004: Jan Basile
Chronic kidney disease: it's time to recognize its presence in our patients with hypertension.
Journal of clinical hypertension (Greenwich, Conn.) 2004;6(10):548-52.
2004: Michael J Bloch; Jan Basile
Clinical insights into the diagnosis and management of renovascular disease. An evidence-based review.
Minerva medica 2004;95(5):357-73.
2004: Elizabeth I Majeski; Colin E Widener; Jan Basile
Hypertension and dementia: does blood pressure control favorably affect cognition?
Current hypertension reports 2004;6(5):357-62.
2004: Donald G Vidt; Jan Basile
Hypertension curriculum review. The importance of systolic blood pressure elevation in elderly persons.
Journal of clinical hypertension (Greenwich, Conn.) 2004;6(8):461-5.
2004: Marvin Moser; Douglas D Schocken; Jan Basile; William Cushman
Hypertension and heart failure. Roundtable discussion.
Journal of clinical hypertension (Greenwich, Conn.) 2004;6(6):326-32.
2004: Joshua I Barzilay; Barry R Davis; Judy Bettencourt; Karen L Margolis; David C Goff; Henry Black; Gabriel Habib; Allan Ellsworth; Rex W Force; Thomas Wiegmann; Jerry O Ciocon; Jan Basile
Cardiovascular outcomes using doxazosin vs. chlorthalidone for the treatment of hypertension in older adults with and without glucose disorders: a report from the ALLHAT study.
Journal of clinical hypertension (Greenwich, Conn.) 2004;6(3):116-25.
2004: Jan Basile
Analysis of recent papers in hypertension.
Journal of clinical hypertension (Greenwich, Conn.) 2004;6(2):96-101.
2004: Jan Basile; Daniel T Lackland; Jeffrey M Basile; Jessica E Riehle; Brent M Egan
A statewide primary care approach to cardiovascular risk factor control in high-risk diabetic and nondiabetic patients with hypertension.
Journal of clinical hypertension (Greenwich, Conn.) 2004;6(1):18-25.
2003: Marvin Moser; Jan Basile; Domenic A Sica
Roundtable discussion: Electrolytes in cardiovascular disease and hypertension.
Journal of clinical hypertension (Greenwich, Conn.) 2003;5(6):402-7.
2003: Brent M Egan; Jan Basile
Controlling blood pressure in 50% of all hypertensive patients: an achievable goal in the healthy people 2010 report?
Journal of investigative medicine : the official publication of the American Federation for Clinical Research 2003;51(6):373-85.
2003: Jan Basile
Analysis of recent papers in hypertension. Post menopausal hormone replacement therapy prevents diabetes.
Journal of clinical hypertension (Greenwich, Conn.) 2003;5(5):353-4.
2003: Jan Basile
Analysis of recent papers in hypertension. Need for more aggressive blood pressure control in diabetes.
Journal of clinical hypertension (Greenwich, Conn.) 2003;5(5):352-3.
2003: Jan Basile
Optimizing antihypertensive treatment in clinical practice.
American journal of hypertension 2003;16(9 Pt 2):13S-17S.
2003: Michael J Bloch; Jan Basile
The diagnosis and management of renovascular disease: a primary care perspective. Part II. Issues in management.
Journal of clinical hypertension (Greenwich, Conn.) 2003;5(4):261-8.
2003: Melanie Giese; Daniel T Lackland; Jan Basile; Brent M Egan
2003 update on the Hypertension Initiative of South Carolina. Bringing South Carolina from "worst to first" in cardiovascular health.
Journal of the South Carolina Medical Association (1975) 2003;99(6):157-61.
2003: Michael J Bloch; Jan Basile
The diagnosis and management of renovascular disease: a primary care perspective. Part I. Making the diagnosis.
Journal of clinical hypertension (Greenwich, Conn.) 2003;5(3):210-8.
2003: Jan Basile
Titration of beta-blockers in heart failure. How to maximize benefit while minimizing adverse events.
Postgraduate medicine 2003;113(3):63-70; quiz 3.
2003: Jan Basile
Systolic blood pressure elevation: it's where the action is.
Drugs & aging 2003;20(4):287-8.
2002: Jan Basile
Serial hemodynamic measurements allow better blood pressure control than clinical judgment in those with refractory hypertension.
Journal of clinical hypertension (Greenwich, Conn.) 2002;4(6):434-5.
2002: Jan Basile
Coffee intake over 33 years is not associated with developing hypertension.
Journal of clinical hypertension (Greenwich, Conn.) 2002;4(6):434.
2002: Jan Basile
Gaining weight increases the risk for the development of heart failure.
Journal of clinical hypertension (Greenwich, Conn.) 2002;4(6):433.
2002: Jan Basile
Systolic blood pressure.
BMJ (Clinical research ed.) 2002;325(7370):917-8.
2002: Shakaib U Rehman; Dennis W Cope; Jan Basile
Metastatic gastroesophageal adenocarcinoma to skeletal muscle: a unique event.
Southern medical journal 2002;95(9):1076-8.
2002: Brent M Egan; Daniel T Lackland; Jan Basile
American Society of Hypertension regional chapters: leveraging the impact of the clinical hypertension specialist in the local community.
American journal of hypertension 2002;15(4 Pt 1):372-9.
2002: Marvin Moser; Jan Basile; Edgar R Miller; Keith C Ferdinand
Roundtable discussion: hypertension, renal disease, and diabetes.
Journal of clinical hypertension (Greenwich, Conn.) 2002;4(2):113-9.
2002: Jan Basile
Hypertension in the elderly: a review of the importance of systolic blood pressure elevation.
Journal of clinical hypertension (Greenwich, Conn.) 2002;4(2):108-12, 119.
2002: Jan Basile
Halting the progression of heart failure: finding the optimal combination therapy.
Cleveland Clinic journal of medicine 2002;69(2):104-5, 109-10, 112.
2002: Jan Basile
Most antihypertensives have similar efficacy and safety: a meta-analysis.
Journal of clinical hypertension (Greenwich, Conn.) 2002;4(1):50-1.
2002: Jan Basile
ACE inhibitor-associated cough lessened with iron supplementation.
Journal of clinical hypertension (Greenwich, Conn.) 2002;4(1):49-50.
2002: Jan Basile
Estrogen replacement does not prevent recurrent stroke or death in postmenopausal women after an ischemic stroke.
Journal of clinical hypertension (Greenwich, Conn.) 2002;4(1):48-9.
2002: Jan Basile
Blood pressure reduction in those with cerebrovascular disease prevents secondary stroke.
Journal of clinical hypertension (Greenwich, Conn.) 2002;4(1):47-8.
2001: Jan Basile
Hypertension 2001: pearls for the clinician.
Southern medical journal 2001;94(11):1054-7.
2001: Jan Basile
Aspirin and angiotensin-converting enzyme inhibitors are safe when taken together after acute myocardial infarction in patients with left ventricular dysfunction.
Journal of clinical hypertension (Greenwich, Conn.) 2001;3(6):376-7.
2001: Jan Basile
An angiotensin receptor blocker plus a diuretic is most effective in lowering blood pressure in the African American with hypertension on a supplemental salt diet.
Journal of clinical hypertension (Greenwich, Conn.) 2001;3(5):316-8.
2001: Jan Basile
Blacks with hypertension, renal insufficiency, and baseline proteinuria benefit more from ACE inhibition than from calcium channel blockade.
Journal of clinical hypertension (Greenwich, Conn.) 2001;3(5):315-6.
2001: Jan Basile
Hypertension 2001: how will JNC VII be different from JNC VI?
Southern medical journal 2001;94(9):889-90.
2001: Jan Basile
Do blacks with ventricular dysfunction benefit from ACE inhibitor therapy?
Journal of clinical hypertension (Greenwich, Conn.) 2001;3(5):313-5.
2001: Jan Basile
Analyzing the national cholesterol education program adult treatment panel III report: is new better?
Journal of clinical hypertension (Greenwich, Conn.) 2001;3(5):292-5.
2001: Jan Basile
Salt sensitivity predicts mortality independently of elevated blood pressure: a 27-year follow-up study.
Journal of clinical hypertension (Greenwich, Conn.) 2001;3(4):258-9.
2001: Jan Basile
Renal insufficiency predicts cardiovascular disease in high-risk individuals: the benefit of ramipril in the HOPE study. Heart Outcomes and Prevention Evaluation.
Journal of clinical hypertension (Greenwich, Conn.) 2001;3(4):256-7.
2001: Joshua I Barzilay; C L Jones; Barry R Davis; Jan Basile; D C Goff; Jerry O Ciocon; M E Sweeney; O S Randall
Baseline characteristics of the diabetic participants in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
Diabetes care 2001;24(4):654-8.
2001: Jan Basile
New strategies for improving heart failure management: a primary care perspective.
Southern medical journal 2001;94(2):166-74.
2000: Jan Basile
Combination agents as a means of improving adherence and other aspects of the sixth Joint National Committee Report.
Southern medical journal 2000;93(5):534-6.
1999: D Jones; Jan Basile; William Cushman; Brent M Egan; Carlos M Ferrario; Martha N Hill; Daniel T Lackland; George Mensah; M Moore; Elizabeth Ofili; Edward J Roccella; R Smith; H Taylor
Managing hypertension in the southeastern United States: applying the guidelines from the Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC VI).
The American journal of the medical sciences 1999;318(6):357-64.
1993: Jan Basile; Y Liel; J Shary; Norman H Bell
Increased calcium intake does not suppress circulating 1,25-dihydroxyvitamin D in normocalcemic patients with sarcoidosis.
The Journal of clinical investigation 1993;91(4):1396-8.